Serveur d'exploration Covid et maladies cardiovasculaires

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.

Identifieur interne : 000306 ( Main/Corpus ); précédent : 000305; suivant : 000307

Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.

Auteurs : Maki Komiyama ; Koji Hasegawa

Source :

RBID : pubmed:32373189

Abstract

The novel coronavirus disease 2019 (COVID-19) has already evolved into a rapidly expanding pandemic. Risk factors for COVID-19, such as cardiovascular disease, chronic obstructive pulmonary disease and diabetes, are all strongly associated with smoking habits. The effects of cigarette smoking on the transmission of the virus and worsening of COVID-19 have been less addressed. Emerging data indicate that smoking history is the major determinant of worsening COVID-19 outcomes. Smoking cessation recovers airway ciliary clearance and immune function. Thus, smoking cessation awareness is strongly encouraged as a public health measure to limit the global impact of COVID-19.

DOI: 10.15420/ecr.2020.11
PubMed: 32373189
PubMed Central: PMC7199122

Links to Exploration step

pubmed:32373189

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.</title>
<author>
<name sortKey="Komiyama, Maki" sort="Komiyama, Maki" uniqKey="Komiyama M" first="Maki" last="Komiyama">Maki Komiyama</name>
<affiliation>
<nlm:affiliation>National Hospital Organization Kyoto Medical Center Kyoto, Japan.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hasegawa, Koji" sort="Hasegawa, Koji" uniqKey="Hasegawa K" first="Koji" last="Hasegawa">Koji Hasegawa</name>
<affiliation>
<nlm:affiliation>National Hospital Organization Kyoto Medical Center Kyoto, Japan.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32373189</idno>
<idno type="pmid">32373189</idno>
<idno type="doi">10.15420/ecr.2020.11</idno>
<idno type="pmc">PMC7199122</idno>
<idno type="wicri:Area/Main/Corpus">000306</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000306</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.</title>
<author>
<name sortKey="Komiyama, Maki" sort="Komiyama, Maki" uniqKey="Komiyama M" first="Maki" last="Komiyama">Maki Komiyama</name>
<affiliation>
<nlm:affiliation>National Hospital Organization Kyoto Medical Center Kyoto, Japan.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hasegawa, Koji" sort="Hasegawa, Koji" uniqKey="Hasegawa K" first="Koji" last="Hasegawa">Koji Hasegawa</name>
<affiliation>
<nlm:affiliation>National Hospital Organization Kyoto Medical Center Kyoto, Japan.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">European cardiology</title>
<idno type="eISSN">1758-3764</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The novel coronavirus disease 2019 (COVID-19) has already evolved into a rapidly expanding pandemic. Risk factors for COVID-19, such as cardiovascular disease, chronic obstructive pulmonary disease and diabetes, are all strongly associated with smoking habits. The effects of cigarette smoking on the transmission of the virus and worsening of COVID-19 have been less addressed. Emerging data indicate that smoking history is the major determinant of worsening COVID-19 outcomes. Smoking cessation recovers airway ciliary clearance and immune function. Thus, smoking cessation awareness is strongly encouraged as a public health measure to limit the global impact of COVID-19.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">32373189</PMID>
<DateRevised>
<Year>2020</Year>
<Month>05</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1758-3764</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>15</Volume>
<PubDate>
<Year>2020</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>European cardiology</Title>
<ISOAbbreviation>Eur Cardiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.</ArticleTitle>
<Pagination>
<MedlinePgn>e16</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15420/ecr.2020.11</ELocationID>
<Abstract>
<AbstractText>The novel coronavirus disease 2019 (COVID-19) has already evolved into a rapidly expanding pandemic. Risk factors for COVID-19, such as cardiovascular disease, chronic obstructive pulmonary disease and diabetes, are all strongly associated with smoking habits. The effects of cigarette smoking on the transmission of the virus and worsening of COVID-19 have been less addressed. Emerging data indicate that smoking history is the major determinant of worsening COVID-19 outcomes. Smoking cessation recovers airway ciliary clearance and immune function. Thus, smoking cessation awareness is strongly encouraged as a public health measure to limit the global impact of COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020, Radcliffe Cardiology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Komiyama</LastName>
<ForeName>Maki</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>National Hospital Organization Kyoto Medical Center Kyoto, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hasegawa</LastName>
<ForeName>Koji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>National Hospital Organization Kyoto Medical Center Kyoto, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>04</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Eur Cardiol</MedlineTA>
<NlmUniqueID>101574780</NlmUniqueID>
<ISSNLinking>1758-3756</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Smoking</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">pandemic</Keyword>
</KeywordList>
<CoiStatement>Disclosure: The authors have no conflicts of interest to declare.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32373189</ArticleId>
<ArticleId IdType="doi">10.15420/ecr.2020.11</ArticleId>
<ArticleId IdType="pmc">PMC7199122</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>BMC Public Health. 2018 May 2;18(1):574</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29716568</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2009 Aug;41(2):189-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19131644</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2004 Nov 8;164(20):2206-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15534156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chin Med J (Engl). 2020 May 5;133(9):1032-1038</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32118640</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Mar 19;382(12):1177-1179</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32074444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2020 Mar;21(3):335-337</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32066541</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2020 Apr;21(4):e180</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32142622</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 Apr;8(4):e21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32171062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Allergy. 2020 Mar 20;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32196678</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Allergy Clin Immunol. 2000 Aug;106(2):280-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10932071</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 10;43(0):E034</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32153171</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32015507</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mediators Inflamm. 2020 Feb 29;2020:6705428</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32189996</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunology. 2003 Jul;109(3):365-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12807482</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000306 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000306 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CardioCovidV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32373189
   |texte=   Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32373189" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CardioCovidV1 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Aug 4 15:08:30 2020. Site generation: Wed Jan 27 11:23:02 2021